The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort
Open accessAbstract
Abstract Rationale Interstitial lung disease (ILD) represents a major challenge in systemic sclerosis (SSc), but there are no precise, population-based data on its overall impact, limiting opportunities for screening and management strategies. Objectives Evaluate impact of ILD in a unique, nationwide, population-based SSc cohort. Methods ILD was assessed prospectively in the Norwegian SSc (Nor-SSc) cohort, including all 815 patients with SSc resident in the country from 2000 to 2012. Lung high-resolution computed tomography (HRCT) scans were available for fibrosis quantification at baseline (n = 650, 80%) and follow-up. Pulmonary function tests were assessed at baseline (n = 703, 86%) and follow-up. Vital status and standardized mortality ratios (SMRs) were estimated at study end (2018) in the 630 incident Nor-SSc cases and 15 individually matched control subjects. Cumulative survival rates were computed. Measurements and Main Results At baseline, 50% of the subjects with SSc (n = 324) had ILD by HRCT and 46% displayed pulmonary function declines consistent with ILD progression. Mortality correlated with extent of lung fibrosis as SMR increased from 2.2 with no fibrosis to 8.0 with greater than 25% fibrosis. SMR was inversely related to baseline FVC% and increased at all FVC levels below 100%. In patients with normal-range baseline FVC (80–100%), the 5- and 10-year survival rates correlated with presence or absence of lung fibrosis, being 83% and 80%, respectively, with no fibrosis and 69% and 56%, respectively, with lung fibrosis (P = 0.03). Conclusions The mere presence of ILD at baseline appears to affect outcome in SSc, suggesting that all patients with SSc should undergo a baseline pulmonary function test and lung HRCT screening to diagnose ILD early and tailor further management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Quanjer, P. H., Stanojevic, S., Cole, T. J., Baur, X., Hall, G. L., Culver, B. H., Enright, P. L., Hankinson, J. L., Ip, M. S. M., Zheng, J., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00080312 · Cited by 5,919
Lung volumes and forced ventilatory flows
Quanjer, P. H., Tammeling, G. J., Cotes, J. E., Pedersen, O. F., Peslin, R., & Yernault, J.-C. (1993) · European Respiratory Journal · doi:10.1183/09041950.005s1693 · Cited by 5,318
Fleischner Society: Glossary of Terms for Thoracic Imaging
Hansell, D. M., Bankier, A. A., MacMahon, H., McLoud, T. C., Müller, N. L., & Remy, J. (2008) · Radiology · doi:10.1148/radiol.2462070712 · Cited by 4,198
van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S. R., Baron, M., Tyndall, A., Matucci-Cerinic, M., Naden, R. P., Medsger, T. A., Carreira, P. E., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204424 · Cited by 2,886
Denton, C. P., & Khanna, D. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30933-9 · Cited by 2,212
Cyclophosphamide versus placebo in scleroderma lung disease
Tashkin, D. P., Elashoff, R., Clements, P. J., Goldin, J., Roth, M. D., Furst, D. E., Arriola, E., Silver, R., Strange, C., Bolster, M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055120 · Cited by 1,677
Changes in causes of death in systemic sclerosis, 1972–2002
Steen, V. D., & Medsger, T. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.066068 · Cited by 1,528
Interstitial Lung Disease in Systemic Sclerosis: A Simple Staging System
Goh, N. S. L., Desai, S. R., Veeraraghavan, S., Hansell, D. M., Copley, S. J., Maher, T. M., Corte, T. J., Sander, C. R., Ratoff, J., Devaraj, A., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-877oc · Cited by 1,230
Update of EULAR recommendations for the treatment of systemic sclerosis
Kowal-Bielecka, O., Fransen, J., Avouac, J., Becker, M., Kulak, A., Allanore, Y., Distler, O., Clements, P., Cutolo, M., Czirjak, L., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209909 · Cited by 1,104
Self-citationTashkin, D. P., Roth, M. D., Clements, P. J., Furst, D. E., Khanna, D., Kleerup, E. C., Goldin, J., Arriola, E., Volkmann, E. R., Kafaja, S., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30152-7 · Cited by 1,078
Walker, U. A., Tyndall, A., Czirják, L., Denton, C., Farge-Bancel, D., Kowal-Bielecka, O., Müller-Ladner, U., Bocelli-Tyndall, C., & Matucci-Cerinic, M. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062901 · Cited by 929
Allanore, Y., Simms, R., Distler, O., Trojanowska, M., Pope, J., Denton, C. P., & Varga, J. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.2 · Cited by 876
Mapping and predicting mortality from systemic sclerosis
Elhai, M., Meune, C., Boubaya, M., Avouac, J., Hachulla, E., Balbir-Gurman, A., Riemekasten, G., Airò, P., Joven, B., Vettori, S., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211448 · Cited by 691
Fibrotic Idiopathic Interstitial Pneumonia: The Prognostic Value of Longitudinal Functional Trends
Latsi, P. I., du Bois, R. M., Nicholson, A. G., Colby, T. V., Bisirtzoglou, D., Nikolakopoulou, A., Veeraraghavan, S., Hansell, D. M., & Wells, A. U. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1245oc · Cited by 583
Prognostic Implications of Physiologic and Radiographic Changes in Idiopathic Interstitial Pneumonia
Flaherty, K. R., Mumford, J. A., Murray, S., Kazerooni, E. A., Gross, B. H., Colby, T. V., Travis, W. D., Flint, A., Toews, G. B., Lynch, J. P., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200209-1112oc · Cited by 513
Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis
Nihtyanova, S. I., Schreiber, B. E., Ong, V. H., Rosenberg, D., Moinzadeh, P., Coghlan, J. G., Wells, A. U., & Denton, C. P. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38390 · Cited by 460
Pathogenesis of Systemic Sclerosis
Pattanaik, D., Brown, M., Postlethwaite, B. C., & Postlethwaite, A. E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00272 · Cited by 405
Zappala, C. J., Latsi, P. I., Nicholson, A. G., Colby, T. V., Cramer, D., Renzoni, E. A., Hansell, D. M., du Bois, R. M., & Wells, A. U. (2010) · European Respiratory Journal · doi:10.1183/09031936.00155108 · Cited by 372
Goh, N. S., Hoyles, R. K., Denton, C. P., Hansell, D. M., Renzoni, E. A., Maher, T. M., Nicholson, A. G., & Wells, A. U. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40130 · Cited by 354
Physiology Is a Stronger Predictor of Survival than Pathology in Fibrotic Interstitial Pneumonia
Jegal, Y., Kim, D. S., Shim, T. S., Lim, C.-M., Do Lee, S., Koh, Y., Kim, W. S., Kim, W. D., Lee, J. S., Travis, W. D., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200403-331oc · Cited by 308
Suliman, Y. A., Dobrota, R., Huscher, D., Nguyen‐Kim, T. D. L., Maurer, B., Jordan, S., Speich, R., Frauenfelder, T., & Distler, O. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39405 · Cited by 222
Volkmann, E. R., Tashkin, D. P., Sim, M., Li, N., Goldmuntz, E., Keyes-Elstein, L., Pinckney, A., Furst, D. E., Clements, P. J., Khanna, D., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213708 · Cited by 197
Khanna, D., Mittoo, S., Aggarwal, R., Proudman, S. M., Dalbeth, N., Matteson, E. L., Brown, K., Flaherty, K., Wells, A. U., Seibold, J. R., et al. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.141182 · Cited by 193
Moore, O. A., Goh, N., Corte, T., Rouse, H., Hennessy, O., Thakkar, V., Byron, J., Sahhar, J., Roddy, J., Gabbay, E., et al. (2013) · Rheumatology · doi:10.1093/rheumatology/kes289 · Cited by 192
High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis.
Launay, D., Rémy-Jardin, M., Michon-Pasturel, U., Mastora, I., HACHULLA, E., Lambert, M., Delannoy, V., Queyrel, V., Duhamel, A., Matran, R., et al. (2006) · PubMed · Cited by 189
Assassi, S., Sharif, R., Lasky, R. E., McNearney, T. A., Estrada-Y-Martin, R. M., Draeger, H., Nair, D. K., Fritzler, M. J., Reveille, J. D., Arnett, F. C., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3125 · Cited by 180
Wells, A. U., Hansell, D. M., Rubens, M. B., King, A. D., Cramer, D., Black, C. M., & Du Bois, R. M. (1997) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199707)40:7<1229::aid-art6>3.0.co;2-w · Cited by 162
Wu, W., Jordan, S., Becker, M. O., Dobrota, R., Maurer, B., Fretheim, H., Ye, S., Siegert, E., Allanore, Y., Hoffmann‐Vold, A., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213201 · Cited by 154
Self-citationLeft Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis
Tennøe, A. H., Murbræch, K., Andreassen, J. C., Fretheim, H., Garen, T., Gude, E., Andreassen, A., Aakhus, S., Molberg, Ø., & Hoffmann‐Vold, A. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.068 · Cited by 135
Self-citationPavec, J. L., Girgis, R. E., Lechtzin, N., Mathai, S. C., Launay, D., Hummers, L. K., Zaiman, A., Sitbon, O., Simonneau, G., Humbert, M. J. C., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30423 · Cited by 132
Frantz, C., Avouac, J., Distler, O., Amrouche, F., Godard, D., Kennedy, A. T., Connolly, K., Varga, J., Matucci‐Cerinic, M., & Allanore, Y. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.02.005 · Cited by 125
Scleroderma lung: Initial forced vital capacity as predictor of pulmonary function decline
Plastiras, S. C., Karadimitrakis, S. P., Ziakas, P. D., Vlachoyiannopoulos, P. G., Moutsopoulos, H. Μ., & Tzelepis, G. E. (2006) · Arthritis Care & Research · doi:10.1002/art.22099 · Cited by 95
Major lung complications of systemic sclerosis
Denton, C. P., Wells, A. U., & Coghlan, G. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0062-0 · Cited by 91
Walker, U. A., Tyndall, A., Czirják, L., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.091348 · Cited by 82
Interstitial lung disease in systemic sclerosis: progress in screening and early diagnosis
Molberg, Ø., & Hoffmann‐Vold, A. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000323 · Cited by 51
Self-citationEmerging strategies for treatment of systemic sclerosis
Khanna, D., Distler, J. H. W., Sandner, P., & Distler, O. (2016) · Journal of Scleroderma and Related Disorders · doi:10.5301/jsrd.5000207 · Cited by 47
CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis
Hoffmann‐Vold, A., Hesselstrand, R., Fretheim, H., Ueland, T., Andreassen, A. K., Brunborg, C., Palchevskiy, V., Midtvedt, Ø., Garen, T., Aukrust, P., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40534 · Cited by 40
Self-citationElinoff, J. M., Agarwal, R., Barnett, C. F., Benza, R. L., Cuttica, M. J., Gharib, A. M., Gray, M. P., Hassoun, P. M., Hemnes, A. R., Humbert, M. J. C., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201710-2093pp · Cited by 24
The Fine Line between Success and Failure in Scleroderma Lung Fibrosis Trials
Ryerson, C. J., & Denton, C. P. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201711-2268ed · Cited by 4
Cited by
Volkmann, E. R., Andréasson, K., & Smith, V. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01692-0 · Cited by 616
Wells, A. U., Flaherty, K. R., Brown, K. K., Inoue, Y., Devaraj, A., Richeldi, L., Moua, T., Crestani, B., Wuyts, W. A., Stowasser, S., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30036-9 · Cited by 569
George, P. M., Spagnolo, P., Kreuter, M., Altinisik, G., Bonifazi, M., Martinez, F. J., Molyneaux, P. L., Renzoni, E. A., Richeldi, L., Tomassetti, S., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30355-6 · Cited by 349
Hoffmann-Vold, A.-M., Allanore, Y., Alves, M., Brunborg, C., Airó, P., Ananieva, L. P., Czirják, L., Guiducci, S., Hachulla, E., Li, M., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217455 · Cited by 357
Self-citationHoffmann-Vold, A.-M., Maher, T. M., Philpot, E. E., Ashrafzadeh, A., Barake, R., Barsotti, S., Bruni, C., Carducci, P., Carreira, P. E., Castellví, I., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(19)30144-4 · Cited by 310
Self-citation
Metadata
- Authors
- Hoffmann-Vold, A.-M., Fretheim, H., Halse, A.-K., Seip, M., Bitter, H., Wallenius, M., Garen, T., Salberg, A., Brunborg, C., Midtvedt, Ø., Lund, M. B., Aaløkken, T. M., & Molberg, Ø.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-11-15
- Volume
- 200
- Issue
- 10
- Pages
- 1258-1266
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2958111965
- Cited by
- 257
- References
- 41
- FWCI
- 16.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.